表紙
市場調査レポート

二重チャンバーシリンジ&注射器:デバイス・治療法・市場・予測

Dual Chamber Syringes & Injectors to 2022

発行 Greystone Research Associates 商品コード 281703
出版日 ページ情報 英文
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=101.55円で換算しております。
Back to Top
二重チャンバーシリンジ&注射器:デバイス・治療法・市場・予測 Dual Chamber Syringes & Injectors to 2022
出版日: 2015年09月01日 ページ情報: 英文
担当者のコメント
Greystone Research AssociatesはDDSを専門とする調査会社でDDSの細かなテーマを選びそれぞれ独立したレポートとして発行しています。本レポートはプレフィルドシリンジの中でも特にデュアルチャンバシリンジを取り上げています。充填される製剤のシリンジへの影響、主要な製品の評価、治療領域別の市場分析など、この分野の最新動向を包括的に把握する上でハンディな情報源となっています。
概要

当レポートでは、二重チャンバーシリンジ&注射器市場について調査し、治療注射用凍結乾燥剤市場への影響の分析、治療需要の促進因子の分析、二重チャンバーシリンジ・注射システムの可能性の評価、市場データと予測、および主要サプライヤーのプロファイルなどを提供しています。

エグゼクティブサマリー

注射剤市場の力学

  • デバイスの進化
  • 処方因子
  • 製品固有の工夫の開発
  • 特殊注射装置需要の促進因子
    • 慢性疾患および自己投与
    • 生物製剤の成長
    • 処方および投薬
    • 患者統計の変化
    • 薬剤の経済学、安全性およびコンプライアンス
    • 装置設計および革新
  • 競合情勢
  • 技術市場の促進因子

二重チャンバー注射装置のエコシステム

  • カートリッジ
  • インジェクター
  • シリンジ

二重チャンバーシリンジ&注射装置の評価

  • 製品固有の工夫
  • 特殊装置
  • OEM装置

治療分野:市場データおよび予測

  • 血糖管理
  • 遺伝性疾患
  • ホルモン補充
  • 感染症
  • 代謝性疾患
  • 腫瘍
  • リプロダクティブヘルス
  • その他の治療分野

市場因子

  • デバイス製品戦略
  • デバイスの経済学
  • 製品のブランド戦略
  • 直販マーケティング
  • マネージドケア・医療経済

企業プロファイル

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: DCJ222R

Innovative Devices for Drug Reconstitution

In terms of formulation market share gains, lyophilized injectable drugs are the fastest growing drug formulation segment. From 1990 to 1998 the share of newly approved lyophilized drugs as a share of all injectable/infusible drugs was 11.9%. In 2011, it was 41% and in 2013, injectable/infusible drugs requiring reconstitution made up half of all new approvals. Because a significant number of these drugs are developed for self-administration, they present special challenges for developers. Dual chamber injection devices - designed to simplify reconstitution without patient handling of drug or diluent - have become the mainstay delivery option for this class of drugs. As lyophilized injectables continue to increase in number and market share, dual chamber syringes and injectors will experience double-digit annual unit growth.

The value we provide to our clients and subscribers is best illustrated by our ability to consistently provide strategic direction and market knowledge that contributes to their tactical and strategic decision process.

What You Will Learn

  • What are the currently marketed dual chamber syringes and injection devices and what is their impact on markets for therapeutic injectable lyophilized drugs?
  • What are the therapeutic demand drivers for user-friendly point-of-use reconstitution devices and what specifically is the potential of dual chamber syringes and injector systems?
  • What are the key dual chamber device selection factors, technologies and market development issues?
  • What doses the current dual chamber device market look like, who are the market leaders, and what will this market look like in 2022?
  • What companies supply dual chamber syringe and injector devices, and what are their product activities, business strategies, and corporate alliances and affiliations?
  • How important are pharma-device alliances and design partnerships on dual chamber injection devices?
  • What is the impact of economic, technology, and regulatory factors?

Tailored Research

As technology and products evolve, the level of precision in management decisions required to enable effective company performance is increasing. Such precision cannot be achieved without timely and accurate data about the company's macroscopic operating environment. The information that you and your management team require to execute your business and market strategies is unique to your organization and business model. This is why - in addition to the multi-client reports you will find on our site - we offer client-specific research services that start with customer-defined needs and culminate in assessments and analysis that answer the questions that represent risk to your business strategy. To discuss Greystone's Customer Defined Research services, we invite you to contact us.

Market-driven Product Strategies

A longer life span is expected to translate to a growing number of patients diagnosed with chronic conditions. To counteract the financial and medical infrastructure implications of this trend, pressure from the public sector and managed care organizations will place a premium on therapeutic self-administration, an expectation that is creating an increased interest in routes of administration that are patient-friendly and cost-effective. Pharma company decision makers have come to the realization that for many products, success no longer only depends on the medication itself but also on achieving a consumer-compatible form of packaging and application.

In the past two decades, drug delivery has become a major factor in the advancement of the quality of life and a key factor in the business success of pharmaceutical companies. During this time, syringes and injectors have evolved considerably to address the changing demands of clinicians and their patients. In particular, the appearance and refinement of disposable drug cartridges has created unique opportunities for developers of injectable drugs. For single dose devices, prefilled cartridges contain the exact deliverable dose desired. The custom of overfilling vials to insure availability of the desired dose allows for the possibility of dosing errors that are eliminated with cartridge systems. For recombinant drugs that have an extremely high cost per dose, the economics associated with exact filling are compelling.

Our reports are carefully researched and written to provide timely and insightful analysis of key factors and developments shaping the commercial marketplace. The focused nature of our publications is designed to allow readers to identify emerging demand and growth opportunities in selected markets. Numerous charts, tables and graphs complement the text, with evaluations and assessments of current and probable future market developments, technology issues and business factors - information necessary to compete effectively in the global marketplace.

Table of Contents

Executive Summary

Injectable Drug Market Dynamics

  • Evolution in Device Design
  • Formulation Factors
  • Product Specific Device Development
  • Specialty Injection Device Demand Drivers
    • Chronic Conditions and Self-Administration
    • The Growth of Biologicals
    • Formulation and Dosing
    • Shifting Patient Demographics
    • Drug Economics, Safety and Compliance
    • Device Design and Innovation
  • Competitive Landscape
  • Technology Market Drivers

The Dual Chamber Injection Device Ecosystem

  • Dual Chamber Cartridges
  • Dual Chamber Injectors
  • Dual Chamber Syringes

Dual Chamber Syringe & Injector Device Assessments

  • Product-Specific Devices
  • Specialty Devices
  • OEM Devices

Therapeutic Segments - Market Data & Forecasts

  • Glycemic Control
  • Hereditary Conditions
  • Hormone Replacement
  • Infectious Disease
  • Metabolic Conditions
  • Oncology
  • Reproductive Health
  • Other Therapeutic Segments

Market Factors

  • Device Product Strategies
  • Device Economics
  • Product Branding
  • Direct-to-Consumer Marketing
  • Managed Care Trends

Company Profiles

Back to Top